Shanghai Leadingtac Pharmaceutical Co., Ltd.
PrivateLast Round
Series B
Dec 18, 2025
Total Funding Raised
$42M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Shanghai Leadingtac Pharmaceutical Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B round in December 2025.
Shanghai Leadingtac Pharmaceutical Co., Ltd. is a biotechnology company that develops small-molecule innovative drugs focused on targeted protein degradation for the treatment of autoimmunity and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Leadingtac Pharmaceutical Co., Ltd. Comparables
Compare Shanghai Leadingtac Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gluetacs Therapeutics | 89% | |
| HealZen Therapeutics Co., Ltd. | 86% | |
| Ranok Therapeutics | 83% |
For institutional investors. Book with your work email.
Shanghai Leadingtac Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 18, 2025 | ||||
| Series A | Nov 18, 2024 | ||||
| Pre Seed | Nov 8, 2021 | ||||
| Angel | Nov 1, 2019 |
For institutional investors. Book with your work email.
Shanghai Leadingtac Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Kangcheng Investment Management Co., Ltd. | Series B |
| YuanBio Venture Capital | Pre Seed |
| Lapam Capital | Series B, Series A |
| Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. | Series A |
| 湖南天瑞丰年私募股权基金管理有限公司 | Series A |
| CDH VGC | Series B |
| Hankang Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors grew 1074% MoM.
- Jan 6, 2026
Monthly visitors increased 230% MoM.
For institutional investors. Book with your work email.
Shanghai Leadingtac Pharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Leadingtac Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Leadingtac Pharmaceutical Co., Ltd. a public or private company?
Shanghai Leadingtac Pharmaceutical Co., Ltd. is a private company.
What is the current stock price of Shanghai Leadingtac Pharmaceutical Co., Ltd.?
Shanghai Leadingtac Pharmaceutical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Leadingtac Pharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Leadingtac Pharmaceutical Co., Ltd. worth (valuation)?
Valuation information for Shanghai Leadingtac Pharmaceutical Co., Ltd. is not publicly available.
Can I buy Shanghai Leadingtac Pharmaceutical Co., Ltd. stock?
Shanghai Leadingtac Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Leadingtac Pharmaceutical Co., Ltd.'s last funding round?
Shanghai Leadingtac Pharmaceutical Co., Ltd.'s most recent funding round was Series B on December 18, 2025.
Who are the main investors in Shanghai Leadingtac Pharmaceutical Co., Ltd.?
Key investors in Shanghai Leadingtac Pharmaceutical Co., Ltd. include YuanBio Venture Capital, Lapam Capital, Hankang Capital.
Will Shanghai Leadingtac Pharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Leadingtac Pharmaceutical Co., Ltd..
How can I track Shanghai Leadingtac Pharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Leadingtac Pharmaceutical Co., Ltd.'s shares on secondary markets.